Obesity has become a worldwide epidemic, caused by many factors such as genetic regulatory elements, unhealthy diet, and lack of exercise.
MicroRNAs (
miRNAs) are non-coding single-stranded
RNA classes, which are about 22
nucleotides in length and highly conserved among species. In the last decade, a series of
miRNAs were identified as therapeutic targets for
obesity. In the present study, we found that miR-126b-5p was associated with adipogenesis. miR-126b-5p overexpression promoted the proliferation of 3T3-L1 preadipocytes by upregulating the expression of proliferation-related genes and downregulating the expression of apoptosis-related genes; the inhibition of miR-126b-5p gave rise to opposite results. Similarly, miR-126b-5p overexpression could promote the differentiation of 3T3-L1 preadipocytes by increasing the expression of
lipid deposition genes and
triglyceride (TG) and total
cholesterol (TC) levels. Moreover,
luciferase reporter assay demonstrated that
adiponectin receptor 2 (Adipor2) and
acyl-CoA dehydrogenase, long chain (ACADL) were the direct target genes of miR-126b-5p. Moreover, overexpression of miR-126b-5p could exacerbate the clinical symptoms of
obesity when mice were induced by a high-fat diet, including increased adipose tissue weight, adipocyte volume, and
insulin resistance. Interestingly, overexpression of miR-126b-5p in preadipocytes and mice could significantly increase total
fatty acid content and change the
fatty acid composition of adipose tissue. Taken together, the present study showed that miR-126b-5p promotes
lipid deposition in vivo and in vitro, indicating that miR-126b-5p is a potential target for treating
obesity.